Hematology NewsIbrutinib tops chlorambucil against CLLJuly 10, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell LymphomaRare Diseases
Hematology NewsR2-CHOP doesn’t improve survival in DLBCLJuly 10, 2019B Cell LymphomaDLBCLLymphoma & Plasma Cell Disorders
Hematology NewsCNS-directed therapy appears more effective for synDLBCLJuly 9, 2019B Cell LymphomaLymphoma & Plasma Cell DisordersDLBCL
Hematology NewsInfluenza vaccination status in DLBCL poorly documentedJuly 5, 2019B Cell LymphomaPatient & Survivor CareDLBCL
Hematology NewsRituximab and vemurafenib could challenge frontline chemotherapy for HCLJune 26, 2019B Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsCell count ratios appear to predict thromboembolism in lymphomaJune 25, 2019ThrombosisLymphoma & Plasma Cell DisordersPatient & Survivor CareHodgkin LymphomaB Cell Lymphoma
Hematology NewsHedgehog signaling offers prognostic, therapeutic potential in CLLJune 25, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology TimesBET inhibitors may target oncogene in ABC-like DLBCLJune 21, 2019Lymphoma & Plasma Cell DisordersB Cell LymphomaTranslational Research
Hematology NewsBispecific CAR T-cell therapy yields complete responses in relapsed/refractory non-Hodgkin lymphomasJune 21, 2019Aggressive LymphomasImmunotherapyLymphoma & Plasma Cell DisordersImmuno-oncologyLeukemia, Myelodysplasia, TransplantationB Cell LymphomaMantle Cell Lymphoma
Hematology News5F9 plus rituximab take a bite out of drug-resistant NHLJune 18, 2019Aggressive LymphomasIndolent LymphomaLymphoma & Plasma Cell DisordersB Cell LymphomaFollicular Lymphoma
Hematology NewsObinutuzumab provides strong early responses in untreated MCLJune 17, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology News‘Encouraging’ responses seen with durvalumab plus R-CHOP in DLBCLJune 17, 2019B Cell LymphomaLymphoma & Plasma Cell DisordersAggressive Lymphomas
